SecBot SecBot
6-K ·Filed Jul 29, 2026

CLGN

CollPlant Biotechnologies Ltd
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001213900-26-082528
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine procedural filing confirming shareholder approval of a previously disclosed proposal. No new material information was provided. Monitor for any subsequent filings detailing the specific terms or outcomes of the approved proposal.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
CLGN ▲ +16.03% at T+60d
NEUTRAL call +16.03% · α vs SPY +11.30% · entry $0.3120 → $0.3620
Entry = T+0 close
Jul 29, 2026
via day close
T+1d
-3.88%
call -3.88% · α -5.55%
$0.2999
settled 3mo ago
T+5d
-0.61%
call -0.61% · α -6.14%
$0.3101
settled 3mo ago
T+20d
-1.44%
call -1.44% · α -6.46%
$0.3075
settled 2mo ago
T+60d
+16.03%
call +16.03% · α +11.30%
$0.3620
settled 6d ago

Price Chart

Loading chart...

Executive Summary

CollPlant Biotechnologies filed a Form 6-K on July 29, 2026, reporting that shareholders at an Extraordinary General Meeting approved a proposal described in a prior July 7, 2026 notice. The filing is a routine procedural update confirming shareholder approval of a previously disclosed item, with no financial figures or material business developments disclosed.

Key Facts

  • Shareholders approved a proposal at the Extraordinary General Meeting held on July 29, 2026.
  • The proposal was previously described in the Company's Notice of Extraordinary General Meeting dated July 7, 2026.
  • No financial figures, share counts, or specific business terms were disclosed in this filing.

Financial Impact

No financial impact disclosed in this filing.

Risk Factors

  • Lack of detail on the approved proposal's terms or financial implications.
  • Potential dilution or corporate action risk depending on the nature of the approved proposal, which was not disclosed here.

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-082528
Document: 0001213900-26-082528-index-headers.html0001213900-26-082528
Document: 0001213900-26-082528-index.html0001213900-26-082528
Document: 0001213900-26-082528.txt0001213900-26-082528
21 reports for CLGN
Performance horizon
100% Hit rate @ T+1 9 of 9 directional calls Went positive at some point 9 of 9 best @ T+60▲ +25.17%May 29, 2026
Filters
Rows
Reports for CLGN — sortable, filterable
TypeNow
Oct 27, 2026
today
144
NEUTRAL ★ 2/10
$3.78awaiting T+1—$3.90 (+3.17%)
Oct 19, 2026
8d ago
3
NEUTRAL ★ 2/10
$3.88 $3.76▼ −3.22%▼ −3.75%$3.90 (+0.52%)
Oct 15, 2026
12d ago
6-K
BEARISH ★ 6/10
$3.68 $3.63▲ +1.49%▲ +0.39%$3.90 (−5.98%)
Oct 9, 2026
18d ago
6-K
BEARISH ★ 5/10
$4.02 $3.91▲ +2.74%▲ +2.72%$3.90 (+2.99%)
Oct 8, 2026
19d ago
SC 13G
NEUTRAL ★ 3/10
$3.97 $3.51▼ −11.59%▼ −12.19%$3.90 (−1.76%)
Oct 8, 2026
19d ago
SC 13D/A
NEUTRAL ★ 3/10
$3.97 $3.51▼ −11.59%▼ −12.19%$3.90 (−1.76%)
Oct 6, 2026
21d ago
6-K
NEUTRAL ★ 3/10
$3.39 $3.46▲ +2.06%▲ +2.30%$3.90 (+15.04%)
Sep 30, 2026
27d ago
6-K
BEARISH ★ 7/10
$3.57 $3.46▲ +3.08%▲ +3.82%$3.90 (−9.24%)
Sep 30, 2026
27d ago
Press Release
BEARISH ★ 5/10
$3.57 $3.46▲ +3.08%▲ +3.82%$3.90 (−9.24%)
Sep 24, 2026
4w ago
6-K
NEUTRAL ★ 4/10
$4.12 $4.25▲ +3.16%▲ +2.61%$3.90 (−5.34%)
Showing 10 of 21

US Market Status

Market Closed — Opens in 8h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 29, 2026